Download postoperative analgesia of sustained

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Bad Pharma wikipedia , lookup

Sol–gel process wikipedia , lookup

Bilastine wikipedia , lookup

Transcript
Postoperative Analgesia of Sustained-Release Buprenorphine, SustainedRelease Meloxicam, and Carprofen Gel in a Model of Incisional Pain in Rats
(Rattus norvegicus)
1*
Seymour ,
1
Adams ,
1
Felt ,
3
Jampachaisri ,
2
Yeomans ,
1
Pacharinsak
Travis L.
Sean C.
Stephen A.
Katechan
David C.
Cholawat
1
2
3
Departments of Comparative Medicine and Anesthesia, Stanford University School of Medicine, Stanford, CA; and Department of
Mathematics, Naresuan University, Phitsanulok, Thailand
Abstract
Postoperative analgesia is a vital aspect of laboratory
animal medicine. Novel analgesic formulations of opioids
and nonsteroidal anti-inflammatory drugs (NSAIDs) have
recently been introduced to the laboratory animal market.
The aim of this study is to investigate whether
postoperative
analgesia
of
sustained-release
buprenorphine (Bup-SR), sustained-release meloxicam
(Melox-SR), or carprofen gel (CG) is effective to control
mechanical and thermal hypersensitivity in a model of
incisional pain in rats. Mechanical and thermal
hypersensitivity were tested daily from day -1 to 4. Rats
were randomly placed into 5 treatment groups: 1) saline
(0.9% NaCl, 1 ml/kg SC twice daily, days 0 to 3); 2) BupHCl (0.05 mg/kg SC twice daily, days 0 to 3); 3) Bup-SR
(1.2 mg/kg SC once before an incision); 4) Melox-SR (4
mg/kg SC once before an incision); 5) CG (1 cup daily from
days -2 to 2). Mechanical hypersensitivity was attenuated
in all treatment groups on days 1-4.
Thermal
hypersensitivity was attenuated in Bup-HCl and Bup-SR
groups, but not in Melox-SR or CG groups, on days 1-4.
These findings suggest that postoperative analgesia of
Bup-SR, but not Melox-SR or CG, is effective to attenuate
mechanical and thermal hypersensitivity in a model of
incisional pain in rats.
Introduction
Many surgical procedures performed in rats cause
postoperative pain for at least 48 hr, requiring personnel to
handle the animals frequently. Bup-HCl, a partial μ-opioid
receptor agonist, is considered the “gold standard” and has
been widely used for postoperative analgesia for many
surgical procedures in laboratory rats due to its long
plasma half-life and effective postoperative analgesia. Due
to its duration of action, it should be administered q 6-12
hrs; repeated dosing results in handling-associated stress
which can significantly alter animal physiology and
research data. Numerous novel formulations of opioid
(sustained-release buprenorphine) and NSAID (sustainedrelease meloxicam or carprofen gel) analgesics have been
recently brought to the laboratory animal market; many
without published efficacy studies. Due to their longer
duration of action and formulations, they may offer
significant refinements to laboratory animal care.
AIM: To investigate whether postoperative analgesia of
sustained-release buprenorphine (Bup-SR), sustainedrelease meloxicam (Melox-SR), or carprofen gel (CG) is
effective to control mechanical and thermal
hypersensitivity in a model of incisional pain in rats.
[1] Brennan TJ, Vandermeulen EP, Gebhart GF. 1996. Pain 64: 493-501.
Methods
Animals: Thirty-three adult male Sprague Dawley rats weighing 350-400 gm.
Results
* Indicates significance (P < 0.05) compared
with day -1
Surgical incision: Rats were anesthetized with isoflurane (day 0). The incisional pain model
was performed on the plantar surface of the left hindpaw (ipsilateral) of each rat based on a
previously established model [1]. Rats recovered from surgery for 1 day prior to behavioral
testing.
Drug administration and experimental groups: Rats were assigned to 1 of 5 treatment
groups: Bup-SR (1.2 mg/kg SC once before an incision); Melox-SR (4 mg/kg SC once before an
incision); CG (1 cup daily from days -2 to 2); Bup-HCl (0.05 mg/kg SC twice daily, days 0 to 3);
control (0.9% NaCl, 1 ml/kg SC twice daily, days 0 to 3). Rats underwent mechanical and
thermal hypersensitivity testing once daily on day -1 and 1-4.
Behavioral Testing
• Mechanical hypersensitivity (no. of foot raises): Rats were placed in a clear plastic chamber.
Von Frey monofilaments with calibrated bending forces were used to deliver punctate
mechanical stimuli (10 g force). No. of foot raises evoked by Von Frey monofilaments were
obtained for 10 consecutive trials for each hindpaw. Mechanical hypersensitivity was defined
as a significant increase in foot raise frequency evoked by Von Frey monofilaments. The right
hindpaw (contralateral) served as a control.
• Thermal hypersensitivity (thermal latency): Rats were placed in a clear plastic chamber. A 50
W light bulb was focused on the middle of the plantar surface of each hindpaw for 4
consecutive trials. Thermal (paw withdrawal) latency (s) was measured as the mean of the last
3 trials. Thermal hypersensitivity was defined as a significant decrease in paw withdrawal
latency evoked by thermal stimuli. The right hindpaw (contralateral) served as a control.
Figure 2. Ipsilateral hindpaw: Mechanical hypersensitivity was
attenuated in all treatment groups on days 1-4.
* Indicates significance (P < 0.05) compared
with day -1
Statistical Analyses: Mean withdrawal responses were analyzed using repeated-measures
ANOVA with Bonferroni correction for multiple comparisons to examine differences in withdrawal
responses between groups and over time. Data were expressed as mean ± SEM. A P value of
less than 0.05 was considered significant.
Figure 3. Ipsilateral hindpaw: Thermal hypersensitivity was
attenuated in Bup-HCl and Bup-SR groups, but not in Melox-SR
or CG, on days 1-4.
Conclusions
These findings suggest that postoperative analgesia of Bup-SR, but
not Melox-SR or CG, is effective to attenuate both mechanical and
thermal hypersensitivity in a model of incisional pain in rats.
Acknowledgments
Funding was provided by the Department of Comparative Medicine,
Stanford University School of Medicine.
Figure 1. Timeline of surgical procedure, behavioral testing, and drug administration.
Contact: [email protected]